L. Powell, R. Seckington, Y. Deugnier, and . Haemochromatosis, Haemochromatosis, The Lancet, vol.388, issue.10045, pp.706-716, 2016.
DOI : 10.1016/S0140-6736(15)01315-X

URL : https://hal.archives-ouvertes.fr/hal-01295665

P. Brissot, M. Ropert, L. Lan, and C. , Non-transferrin bound iron: A key role in iron overload and iron toxicity, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1820, issue.3, pp.403-413, 2012.
DOI : 10.1016/j.bbagen.2011.07.014

URL : https://hal.archives-ouvertes.fr/hal-00739430

B. Bacon, P. Adams, and K. Kowdley, Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases, Hepatology, vol.23, issue.5 Suppl 1, pp.328-371, 2011.
DOI : 10.1155/2009/839308

P. Brissot and F. De-bels, Current Approaches to the Management of Hemochromatosis, Hematology, vol.2006, issue.1
DOI : 10.1182/asheducation-2006.1.36

URL : http://asheducationbook.hematologylibrary.org/content/2006/1/36.full.pdf

A. Pietrangelo, Y. Deugnier, and J. Dooley, EASL clinical practice guidelines for HFE hemochromatosis, J Hepatol, vol.53, pp.3-22, 2010.

D. Swinkels, A. Jorna, and R. Raymakers, Synopsis of the Dutch multidisciplinary guideline for the diagnosis and treatment of hereditary haemochromatosis, Neth J Med, vol.65, pp.452-457, 2007.

S. Mcdonnell, B. Preston, and S. Jewell, A survey of 2,851 patients with hemochromatosis:, The American Journal of Medicine, vol.106, issue.6, pp.619-643, 1999.
DOI : 10.1016/S0002-9343(99)00120-5

P. Guggenbuhl, P. Brissot, and O. Loréal, Haemochromatosis: The bone and the joint, Best Practice & Research Clinical Rheumatology, vol.25, issue.5, pp.649-664, 2011.
DOI : 10.1016/j.berh.2011.10.014

URL : https://hal.archives-ouvertes.fr/hal-00739810

P. Adams and M. Speechley, The effect of arthritis on the quality of life in hereditary hemochromatosis, J Rheumatol, vol.23, pp.707-717, 1996.

A. C. Bardou-jacquet, E. Morcet, J. Manet, and G. , Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosis, Journal of Hepatology, vol.62, issue.3, pp.682-691, 2015.
DOI : 10.1016/j.jhep.2014.10.025

URL : https://hal.archives-ouvertes.fr/hal-01091479

D. Guyader, C. Jacquelinet, and R. Moirand, Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis, Gastroenterology, vol.115, issue.4, pp.929-965, 1998.
DOI : 10.1016/S0016-5085(98)70265-3

M. De-tayrac, M. Roth, and A. Jouanolle, Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis, Journal of Hepatology, vol.62, issue.3, pp.664-72, 2015.
DOI : 10.1016/j.jhep.2014.10.017

URL : https://hal.archives-ouvertes.fr/hal-01091987

R. Desgrippes, F. Laine, and J. Morcet, Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production, Hepatology, vol.281, issue.Suppl 1, pp.1784-92, 2013.
DOI : 10.1074/jbc.M513276200

URL : https://hal.archives-ouvertes.fr/inserm-00834268

S. Bekri, P. Gual, and R. Anty, Increased Adipose Tissue Expression of Hepcidin in Severe Obesity Is Independent From Diabetes and NASH, Gastroenterology, vol.131, issue.3, pp.788-96, 2006.
DOI : 10.1053/j.gastro.2006.07.007

F. Laine and Y. Deugnier, Increased Expression of Hepcidin in Obese Patients: Impact on Phenotypic Expression of Hemochromatosis and Pathophysiology of Dysmetabolic Iron Overload Syndrome, Gastroenterology, vol.131, issue.6, p.2028, 2006.
DOI : 10.1053/j.gastro.2006.10.046

G. Rishi, D. Wallace, and V. Subramaniam, Hepcidin: regulation of the master iron regulator, Bioscience Reports, vol.84, issue.3, 2015.
DOI : 10.1182/blood-2013-07-515957

URL : http://www.bioscirep.org/content/ppbioscirep/35/3/e00192.full.pdf

J. Fernandez-real, W. Ricart-engel, and E. Arroyo, Serum Ferritin as a Component of the Insulin Resistance Syndrome, Diabetes Care, vol.21, issue.1, pp.62-70, 1998.
DOI : 10.2337/diacare.21.1.62

Y. Pawlotsky, L. Dantec, P. Moirand, and R. , Elevated parathyroid hormone 44-68 and osteoarticular changes in patients with genetic hemochromatosis, Arthritis & Rheumatism, vol.61, issue.4, pp.799-806, 1999.
DOI : 10.1002/1529-0131(199904)42:4<799::AID-ANR25>3.0.CO;2-4

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/1529-0131%28199904%2942%3A4%3C799%3A%3AAID-ANR25%3E3.0.CO%3B2-4

K. Allen, L. Gurrin, and C. Constantine, Hereditary Hemochromatosis, New England Journal of Medicine, vol.358, issue.3, pp.221-251, 2008.
DOI : 10.1056/NEJMoa073286

P. Adams and J. Barton, How I treat hemochromatosis, Blood, vol.116, issue.3, pp.317-342, 2010.
DOI : 10.1182/blood-2010-01-261875

URL : http://www.bloodjournal.org/content/bloodjournal/116/3/317.full.pdf

A. Pietrangelo, Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment, Gastroenterology, vol.139, issue.2, pp.393-408, 2010.
DOI : 10.1053/j.gastro.2010.06.013

A. C. Sahinbegovic, E. Dallos, T. Aigner, and E. , Musculoskeletal disease burden of hereditary hemochromatosis, Arthritis & Rheumatism, vol.35, issue.12, pp.3792-3800, 2010.
DOI : 10.1007/s002770100371

URL : http://onlinelibrary.wiley.com/doi/10.1002/art.27712/pdf

P. Richette, C. Eymard, and M. Deberg, Increase in type II collagen turnover after iron depletion in patients with hereditary haemochromatosis, Rheumatology, vol.66, issue.11, pp.760-766, 2010.
DOI : 10.1136/ard.2006.063099

M. Lamkanfi and V. Dixit, Mechanisms and Functions of Inflammasomes, Cell, vol.157, issue.5, pp.1013-1035, 2014.
DOI : 10.1016/j.cell.2014.04.007

URL : https://doi.org/10.1016/j.cell.2014.04.007

A. Latourte, A. Frazier, and C. Briere, Interleukin-1 receptor antagonist in refractory haemochromatosis-related arthritis of the hands, Annals of the Rheumatic Diseases, vol.72, issue.5, pp.783-787, 2013.
DOI : 10.1136/annrheumdis-2012-202738

K. Nakamura, T. Kawakami, and N. Yamamoto, Activation of the NLRP3 inflammasome by cellular labile iron, Experimental Hematology, vol.44, issue.2, 2015.
DOI : 10.1016/j.exphem.2015.11.002

O. Loréal, I. Gosriwatana, and D. Guyader, Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method, Journal of Hepatology, vol.32, issue.5, pp.727-760, 2000.
DOI : 10.1016/S0168-8278(00)80240-8

J. Porter, P. Walter, and L. Neumayr, Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients, British Journal of Haematology, vol.106, issue.5, pp.692-698, 2014.
DOI : 10.1182/blood-2004-10-3982

URL : http://onlinelibrary.wiley.com/doi/10.1111/bjh.13081/pdf

J. Porter, T. De-witte, and M. Cappellini, New insights into transfusion-related iron toxicity: Implications for the oncologist, Critical Reviews in Oncology/Hematology, vol.99, pp.261-71, 2016.
DOI : 10.1016/j.critrevonc.2015.11.017

L. Lan, C. Loréal, O. Cohen, and T. , Redox active plasma iron in C282Y/C282Y hemochromatosis, Blood, vol.105, issue.11, pp.4527-4558, 2005.
DOI : 10.1182/blood-2004-09-3468

A. C. Manuscript, Variables independently associated with worsening of MCP-PIP joints (n = 45/266) Odd ratio